sitagliptin glp 1 agonist How do SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors compare in reducing #mortality and #cardiovascular events in patients with type 2 #diabetes? Find out GLP-1 receptor agonists or DPP-4
Description
Nat Reviews Disease Primers

DPP-4 inhibitors as potential candidates for antihypertensive therapy: Improving vascular inflammation and assisting the action of traditional antihypertensive drugs

Nooms microdose dosing schedule is not one-size-fits-all

Our clinical team reviews your health history to ensure a GLP-1 treatment plan is appropriate for you

It also demonstrated improvements in all prespecified cardiometabolic parameters